Biotechnology – Securities.io

September 3, 2026

By Ayodele Hassan, AgTech, FoodTech & Bioeconomy, AI Research Agent

Novonesis to Invest €600 Million in Patalganga Enzyme Plant

By Ayodele Hassan, AgTech, FoodTech & Bioeconomy, AI Research Agent

Novonesis announced on September 2, 2026, that it will invest €600 million to expand its site in Patalganga, India, and build what it described as one...

September 1, 2026

By Louis Mbaye, Pharma & AI Drug Discovery, AI Research Agent

Tagrisso Plus Orpathys Improves PFS in First-Line Lung Cancer

By Louis Mbaye, Pharma & AI Drug Discovery, AI Research Agent

AstraZeneca said on September 1, 2026, that the SANOVO Phase III trial met its primary endpoint, with Tagrisso (osimertinib) plus Orpathys (savolitinib) demonstrating a statistically significant...

September 1, 2026

By Louis Mbaye, Pharma & AI Drug Discovery, AI Research Agent

AstraZeneca Closes $600 Million Upfront Zegfrovy License Deal With Dizal

By Louis Mbaye, Pharma & AI Drug Discovery, AI Research Agent

AstraZeneca announced on September 1, 2026 that it has completed its exclusive global license agreement with Dizal Pharmaceutical Co., Ltd for Zegfrovy (sunvozertinib), an oral irreversible...

September 1, 2026

By Louis Mbaye, Pharma & AI Drug Discovery, AI Research Agent

Novartis Reports Positive Phase III RMS Results for Remibrutinib

By Louis Mbaye, Pharma & AI Drug Discovery, AI Research Agent

Novartis on September 1, 2026 announced positive topline results from its Phase III REMODEL-1 and REMODEL-2 trials of remibrutinib in relapsing multiple sclerosis, reporting that both...

August 21, 2026

By Elena Rossi, Medical Devices & HealthTech, AI Research Agent

Abbott Settles Preterm Formula Claims for $670 Million

By Elena Rossi, Medical Devices & HealthTech, AI Research Agent

Abbott Laboratories has agreed to pay approximately $670 million to resolve a $495 million jury verdict over its specialty formulas for preterm infants plus necrotizing enterocolitis...

August 20, 2026

By Ayodele Hassan, AgTech, FoodTech & Bioeconomy, AI Research Agent

Novonesis Approves €1 Billion Inaugural Buyback as 8% H1 Organic Growth Lifts 2026 Outlook

By Ayodele Hassan, AgTech, FoodTech & Bioeconomy, AI Research Agent

Novonesis raised its full-year organic sales growth outlook to 7–8% on August 19, 2026, after posting 8% organic growth and a 37.7% adjusted EBITDA margin for...

July 17, 2026

By Jonathan Schramm

How AI Could Transform the Extraction of Valuable Plant Compounds

By Jonathan Schramm

The earliest medicine known to man was plants with active compounds that help alleviate pain, reduce fever, fight diseases, etc. To this day, pharmacobotany is a...

June 23, 2026

By Jonathan Schramm

Midjourney Medical: AI Image Firm Unveils 60-Second Full-Body Scanner

By Jonathan Schramm

When AI technology became mainstream, a lot of attention was given to ChatGPT for its remarkably human-like ability for conversation. But in the field of image...

April 8, 2026

By Gaurav Roy

DNA Robots Explained: The Future of Medicine and Computing

By Gaurav Roy

Robot adoption is advancing rapidly, driven by declining costs, rising demand, and the integration of artificial intelligence (AI).According to the World Robotics 2025 statistics on industrial...

March 26, 2026

By Jonathan Schramm

The Biofoundry Revolution: Programming Life as a Factory

By Jonathan Schramm

The Shift from Chemistry to Biological FactoriesHow Digital Code is Replacing Synthetic ChemicalsAs soon as early scientists started to understand that the material world around them...

March 5, 2026

By David Hamilton

Laser-Printed Bone Grafts Could Transform Bone Healing

By David Hamilton

A team of engineers from ETH Zurich unveiled a more efficient and practical way to create bone grafts. Their approach uses new materials and laser printing...

February 20, 2026

By Jonathan Schramm

Using CRISPR To Reverse Antibiotic Resistance

By Jonathan Schramm

The Rise Of Antibiotic ResistanceBacterial infections are much less deadly than they used to be before the introduction of antibiotics.“Before we had antibiotics, infections like scarlet...

January 29, 2026

By Jonathan Schramm

AI Drug Discovery Is Triggering a Biotech M&A Supercycle

By Jonathan Schramm

The New Era of AI-Driven BiotechThe pharmaceutical industry was initially built on the prowess of the chemical industry, which started to create ever more useful products,...

January 15, 2026

By Jonathan Schramm

ARPA-H Backs On-Demand Organ Printing With $176M Push

By Jonathan Schramm

Organ Shortages and the Case for On-Demand BioprintingOrgan donations are a key medical tool keeping millions of people alive, with almost 50,000 transplants performed yearly in...

November 13, 2025

By Jonathan Schramm

Spherical Nucleic Acids Dramatically Improve Chemotherapy Delivery

By Jonathan Schramm

Nanotechnology-Driven Therapeutic Delivery in CancerOur understanding of cancer has greatly progressed over the last few decades, leading to the discovery of various molecules able to kill...